Sohini Das

2 weeks ago | rediff.com | Sohini Das

'We are looking at what kind of products, diagnostics or other solutions we can offer to become a well-rounded player in a particular disease area globally.'IMAGE: Text. Ahmedabad-based Zydus Lifesciences has recently forayed into medical devices, and companion diagnostics. In a virtual interview, managing director Sharvil Patel told Sohini Das/Business Standard that medicines are only a part of the solution. You have recently forayed into med-devices. What is your gameplan?

3 weeks ago | rediff.com | Sohini Das

A fresh US executive order (EO) which seeks to bring down prices of prescription drugs in the country by up to 90 per cent -- on par with other developed nations -- will affect innovator companies, while sparing the Indian generic drug makers in the short term. US President Donald Trump signed the EO on Monday, directing the US Trade Representative and the Secretary of Commerce to act against foreign countries that “purposefully and unfairly undercut market prices”, driving price hikes in the US.

3 weeks ago | rediff.com | Sohini Das

Automotive (auto) major Tata Motors posted a 51 per cent drop in consolidated net profit for the January–March quarter (Q4) of 2024-25 (FY25), to Rs 8,470 crore, due to a deferred tax asset of almost Rs 9,000 crore in the corresponding quarter of the previous financial year and an exceptional item of Rs 566 crore during the quarter. Revenue was up just 0.5 per cent year-on-year (Y-o-Y) at Rs 1.18 trillion for Q4FY25.

1 month ago | business-standard.com | Sohini Das

Ahmedabad-based Zydus Lifesciences has recently forayed into medical devices and companion diagnostics. In a virtual interaction with Sohini Das , Zydus MD Sharvil Patel says medicines are only a part of the solution. Edited excerpts:When we looked at our next 10-15 years' strategy, we changed our name from a pharmaceutical company to a life-sciences organisation. We would like to play a larger role beyond pharmaceuticals alone, where we can offer better value to patients in a more holistic manner.

1 month ago | rediff.com | Shine Jacob |Sohini Das

Various industry bodies have sought immediate government intervention through the imposition of anti-dumping duties, claiming India has seen a surge in imports of Chinese goods over the past two weeks. Though the recent volume of most Chinese imports cannot be quantified at the moment, domestic players attribute the sudden spike to higher tariffs imposed by the Donald Trump administration in the US.